Provided by Tiger Trade Technology Pte. Ltd.

Anika Therapeutics

21.34
-0.4400-2.02%
Post-market: 21.340.00000.00%19:30 EDT
Volume:124.76K
Turnover:2.72M
Market Cap:285.59M
PE:-77.03
High:22.53
Open:22.35
Low:21.13
Close:21.78
52wk High:22.88
52wk Low:8.37
Shares:13.38M
Float Shares:11.29M
Volume Ratio:0.87
T/O Rate:1.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2770
EPS(LYR):-0.7628
ROE:-2.19%
ROA:-0.87%
PB:2.08
PE(LYR):-27.97

Loading ...

Anika Therapeutics Lifts Outlook After Margin Surge

TIPRANKS
·
Aug 03

Anika Therapeutics is Maintained at Buy by B. Riley Securities

Dow Jones
·
Jul 31

B. Riley Adjusts Anika Therapeutics Price Target to $21 From $18, Maintains Buy Rating

MT Newswires Live
·
Jul 30

Vericel Beats Q2 Revenue Estimates, Boosts Annual Outlook

Reuters
·
Jul 30

Anika Therapeutics Inc : Barrington Research Raises Target Price to $21 from $17

THOMSON REUTERS
·
Jul 30

U.S. Research ROUNDUP-Equinix, Meta, S&P Global

Reuters
·
Jul 30

MiMedx Q2 Sales Fall Less than Expected; Set to Acquire Sanara MedTech

Reuters
·
Jul 30

Beta Bionics Q2 Sales Beat Estimates on Pharmacy Channel Growth

Reuters
·
Jul 30

Anika Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 30

Anika Therapeutics Q2 Revenue Rises, Lifts 2026 Outlook

Reuters
·
Jul 29

Anika Therapeutics Q2 Adj. EPS $0.42 May Not Compare To $(0.08) Estimate, Sales $32.610M Beat $29.215M Estimate

Benzinga Earnings
·
Jul 29

Anika Therapeutics Q2 Revenue USD 32.61 Million

Reuters
·
Jul 29

Anika Therapeutics Q2 Adjusted EPS USD 0.42

THOMSON REUTERS
·
Jul 29

Anika Therapeutics - 2027 Total Company Revenue Guidance Flat to 5% Growth

THOMSON REUTERS
·
Jul 29

Anika Therapeutics Inc Expected to Post a Loss of 8 Cents a Share - Earnings Preview

Reuters
·
Jul 27

Anika Therapeutics to Report Q2 2026 Results, Host Conference Call

Reuters
·
Jul 16

Anika Therapeutics Enters Fifth Amendment to Credit Agreement - SEC Filing

Reuters
·
Jul 15

Anika Therapeutics - Secures $50 Mln Revolving Credit Line Maturing July 10, 2031 - SEC Filing

THOMSON REUTERS
·
Jul 15

Anika Therapeutics Amends Bank of America Revolving Credit Facility, Extends Maturity to 2031

Reuters
·
Jul 15

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jun 06